Vadastuximab

Vadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine.
Read more
€0.00 (tax incl.)
Reference:
HY-P99329
Product Details
HY-P99329

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Cancer-programmed cell death
CAS
1436390-64-5

Menu

Settings